Certain identified information has been excluded from this exhibit because such information both (i) is not material and (ii) would likely cause competitive harm if publicly disclosed.Elevation Oncology, Inc. • May 15th, 2023 • Biological products, (no disgnostic substances) • Delaware
Company FiledMay 15th, 2023 Industry JurisdictionThis letter confirms the agreement (“Agreement”) between you and Elevation Oncology, Inc. (the “Company”) concerning the terms of your separation and offers you the separation compensation we discussed in exchange for a general release of claims and covenant not to sue.